HIV-treatment 'booster drugs' are most likely to have dangerous interactions with methamphetamine, mephedrone, MDMA and ketamine
Ugandan gay men talk about why they do not always use condoms
HIV-positive postpartum women who rapidly re-engage with HIV care more likely to have viral suppression in longer term
Third of people with HIV who use drugs intentionally miss doses of HIV treatment when planning to use drugs
Low-threshold methadone maintenance reduces HIV risk for people who inject drugs
First Brazilian PrEP data reinforce evidence that PrEP is most used by those at greatest risk
Indiana HIV outbreak offers lessons about containing local outbreaks and need for harm reduction
WAVES shows elvitegravir regimen beats boosted atazanavir for women with HIV
Open-label PrEP in Botswana: very high adherence and no HIV infections seen
